A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of EB05 + SOC Vs. Placebo + SOC in Adult Hospitalized Patients with COVID-19

Clinical trial NCT04401475 · SUSPENDED

Trial details

NCT number

NCT04401475

Sponsor

Edesa Biotech Inc.

Status

SUSPENDED

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2020-11-25

Primary completion

2024-12-01

Enrollment

644

View on ClinicalTrials.gov